Due to the extreme efficacy and potential adverse effects of artesunate, it is commonly administered in a hospital setting under the supervision of a healthcare professional. The route of administration varies according to the extent of the malaria infection.
Intravenous (IV) or Intramuscular (IM) Use:
In case of severe malaria infections, the preferred method of administration is usually IV artesunate. As the name suggests, IV artesunate is a form of treatment that is carried out in a center where the condition of the patient is being monitored.
It is a type of treatment that involves injection into a patient’s vein to ensure that the medication being given works within the shortest time possible in order to alleviate the effects that the ailment presents.
- Initial dose: 2.4 mg/kg body weight, weight taken before/taken to account for Vov, given (as) intravenous push.
•Subsequent doses: The same dose is repeated every 12 hours except when the conditions of the patient warrants, or up to a total of three days.
The mechanism of action of Artesunate relies partly on the generation of reactive oxygen species (ROS) which inflict oxidative stress to the malaria parasite.
Once this drug is introduced into the bloodstream, it is quickly activated by heme that occurs as a result of the malaria parasite digesting hemoglobin.
At this stage, ROS is generated and acts in a disruptive manner to the cell membrane, proteins and DNA of the parasite, thus killing it. Artesunate is especially potent because it acts on the parasite at different points within its life cycle the blood stage (the stage during which the parasite attacks the red blood cells) and tissue stage (that within the liver)
Like any medication, Artesunat has its private adverse effects that one may not experience in their lift. These include some of the most common and less severe side effects;
- Nausea and vomiting: These are normal occurrence while taking drugs that are used for their effects on the gastro-intestinal system.
- Tiredness. Patients may feel excessive weakness, more so after suffering malaria which takes a substantial toll on an individual’s body
. • Low or no Blood Pressure (Hypotension) Occasional cases of dizziness or light headedness may occur due to the use of Artesuna, especially after a fast IV administrations. More rare but still of considerable significance are;
• Allergic reactions: This may involve skin itchiness or rashes, or in more serious cases a difficulty in breathing.
The following are some key warnings and precautions that one needs to keep in mind while taking Artesunate;
- Pregnancy and lactation: while artesunate is rated category C, its use should only be when the benefits outdo the risks. It is inadvisable to take this medication in pregnant women and especially the first trimester
- Liver and Kidney Diseases: Where there are existing liver or kidney diseases prior to the commencement of treatment with artesunate, the frequencies of dosage ad
ministration and regimen monitoring need to be altered in patients
• Drug Interactions: Such medications as Artesunate have the potential of interacting with other drugs hence either decreasing its effectiveness or increasing the adverse effects
Antimalarials:
Artesunate may interact with mefloquine and lumefantrine, which are often used in combination therapy for malaria. Any signs of toxicity or adverse effects should be closely monitored.
Anticonvulsants:
Phenytoin or carbamazepine can decrease the efficacy of artesunate as it increases its metabolism.
CYP450 Enzyme Inducers/Inhibitors:
CYP450 inducers, such as rifampicin, lower the plasma concentration of artesunate. On the other hand, CYP450 inhibitors, like ketoconazole, increase the levels of artesunate, which poses a higher risk of side effects.
Other Interactions:
Concomitant use with quinine or quinidine increases the risk of QT interval prolongation.
Monitor and adjust dosing when using artesunate concomitantly with these drugs. Refer to a health care provider for specific recommendations.
The quantity of Artesunate prescribed is subject to the weight, age, and severity of the malaria infection in the patients.
- For adults and children more than or equal to 20 kg:
o The initial dose is 2.4 mg/kg body weight as an injection either iv or im.
o The same dose is given every twelve hours for a maximum of three days depending on the severity of the malaria, including the initial dose.
- For children under 20 kg:
o The dosage is weight-dependent. For example, children in the ten to twenty kg range will get a dose by the provider and not in full.
Artesunate is available for use on prescription only and needs to be prescribed by a qualified medical personnel. It is important to take Artesunate only under the guidance of a physician in order to determine the appropriate amount and watch for possible adverse effects.
Because of the severe complications that come with malaria and the effectiveness of the drug Artesunate self-medication is highly discouraged.
If you suspect you have malaria or have been diagnosed with severe malaria, seek immediate medical attention and follow your healthcare provider’s instructions for treatment with Artesunate
1. What is artesunate?
Artesunate is an antimalarial drug derived from artemisinin, which is extracted from the sweet wormwood plant (Artemisia annua). It is primarily used to treat severe malaria caused by Plasmodium falciparum.
2. How does artesunate work?
Artesunate works by producing reactive oxygen species that damage the malaria parasite’s proteins and membranes, leading to its death.
3. How is artesunate administered?
Artesunate can be administered intravenously (IV), intramuscularly (IM), or orally, depending on the severity of the malaria case.
4. What are the common side effects of artesunate?
Common side effects can include nausea, vomiting, abdominal pain, and allergic reactions. Most side effects are mild and manageable.
5. Is artesunate effective against all types of malaria?
While artesunate is particularly effective against Plasmodium falciparum, it is also sometimes used to treat infections caused by Plasmodium vivax, Plasmodium malariae, and Plasmodium ovale.
6. Can artesunate be used in pregnancy?
The use of artesunate during pregnancy is generally discouraged unless the potential benefits outweigh risks, as studies on its safety in pregnant women are limited.
7. How does artesunate compare to other antimalarial medications?
Artesunate is often more effective and faster-acting than traditional antimalarial drugs like chloroquine or quinine, particularly in severe cases of malaria.
8. What should be done if a dose of artesunate is missed?
If a dose is missed, it should be taken as soon as remembered. However, if it’s almost time for the next dose, skip the missed dose and continue with the regular schedule.
9. Are there any contraindications for artesunate use?
Artesunate should be used with caution in patients with a known hypersensitivity to the drug or its components, and in those with severe liver or kidney impairment.
10. Can artesunate be taken with other medications?
Patients should consult healthcare providers before combining artesunate with other medications, as interactions may occur, especially with drugs that affect liver enzymes.
11. How is artesunate stored?
Artesunate should be stored at room temperature, away from moisture and light. Follow specific storage instructions if provided with the medication.
12. What is the role of artesunate in treating severe malaria?
In severe malaria, artesunate is the first-line treatment due to its rapid action, reducing mortality rates compared to older treatments.
13. Can artesunate be used for prophylaxis against malaria?
Artesunate is not recommended for prophylaxis; other medications like mefloquine or atovaquone-proguanil are preferred for prevention.
14. What should be done if artesunate causes an allergic reaction?
If signs of an allergic reaction (like rash, itching, or difficulty breathing) occur, seek immediate medical attention.
15. Is artesunate available over-the-counter?
Artesunate is a prescription medication in many countries and is not available over-the-counter.
16. How long does artesunate remain effective after administration?
The half-life of artesunate is relatively short; its effects usually last for up to 12 hours, but the treatment might extend over several days depending on the severity of malaria.
17. What are the recommended dosages for artesunate?
Dosages of artesunate vary based on the severity of malaria and patient weight, but a typical dose for severe cases is 2.4 mg/kg IV or IM on the first day, followed by additional doses over the next few days.
18. Can artesunate lead to the development of drug resistance?
Though resistance to artemisinin derivatives, including artesunate, has been reported in some regions, continued surveillance and appropriate use can help mitigate this risk.
19. What should patients know before taking artesunate?
Patients should inform their healthcare provider of any other medical conditions, allergies, or medications they are taking before starting artesunate.
20. How is the effectiveness of artesunate monitored?
The effectiveness of artesunate is monitored by clinical improvement, reduction in fever, and parasitemia (the presence of parasites in the blood), usually within 24 hours of treatment initiation.